Browsing by Author "Hoeven, J.J.M. van der"

Now showing items 1-44 of 44

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial
Steenbruggen, Tessa G.; Steggink, Lars C.; Seynaeve, Caroline M.; Hoeven, J.J.M. van der ; Hooning, Maartje J.; Jager, Agnes; Sonke, Gabe S.; Gietema, Jourik A.
2020, Article / Letter to editor (Jama Oncology, vol. 6, iss. 4, (2020), pp. 528-534)
Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs
Leeneman, B.; Uyl-de Groot, Carin A.; Aarts, M.J.; Akkooi, Alexander C.J. van; Berkmortel, F.W. van den; Eertwegh, A.J. van den; Herbschleb, K.H. ; Hoeven, J.J.M. van der ; Haanen, John B. A. G.; Franken, M.G.
2020, Article / Letter to editor (Cancers, vol. 12, iss. 4, (2020), article 1003)
Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer
Uden, D.J.P. van; Maaren, M.C. van; Strobbe, L. ; Bult, P. ; Stam, M.R.; Hoeven, J.J.M. van der ; Siesling, S.; Wilt, J.H.W. de ; Blanken-Peeters, C.
2020, Article / Letter to editor (Surgical Oncology-Oxford, vol. 33, (2020), pp. 43-50)
Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry
Verheijden, R.J.; May, A.M.; Blank, C.U.; Aarts, M.J.; Berkmortel, F. van den; Eertwegh, A.J. van den; Groot, J.W.B. de; Boers-Sonderen, M.J. ; Hoeven, J.J.M. van der ; Hospers, G.A.; Piersma, D.; Rijn, R.S. van; Tije, A.J. Ten; Veldt, A.A.M. van der; Vreugdenhil, G.; Zeijl, M.C.T. van; Wouters, M.; Haanen, J.; Kapiteijn, E.; Suijkerbuijk, K.P. et al. sine al.
2020, Article / Letter to editor (Clinical Cancer Research, vol. 26, iss. 9, (2020), pp. 2268-2274)
Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
Uden, D.J.P. van; Maaren, M.C. van; Strobbe, L. ; Bult, P. ; Hoeven, J.J. van der ; Siesling, S.; Wilt, J.H.W. de ; Blanken-Peeters, C.
2019, Article / Letter to editor (Breast Cancer Research, vol. 21, iss. 1, (2019), article 113)
Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
Uden, D.J.P. van; Maaren, M.C. van; Bult, P. ; Strobbe, L.J.A.; Hoeven, J.J.M. van der ; Blanken-Peeters, C.; Siesling, S.; Wilt, J.H.W. de
2019, Article / Letter to editor (Breast Cancer Research and Treatment, vol. 176, iss. 1, (2019), pp. 217-226)
Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy
Komen, M.M.; Hurk, C.J. van den; Nortier, J.W.; Ploeg, T. van der; Nieboer, P.; Hoeven, J.J.M. van der ; Smorenburg, C.H.
2019, Article / Letter to editor (Supportive Care in Cancer, vol. 27, iss. 5, (2019), pp. 1919-1925)
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
Groot, S. de; Pijl, H.; Charehbili, A.; Ven, S. van de; Smit, V.T.; Meershoek-Klein Kranenbarg, Elma; Laarhoven, H.W.M. van ; Hoeven, J.J.M. van der ; Nortier, J.W.; Kroep, Judith R.
2019, Article / Letter to editor (Breast Cancer Research, vol. 21, iss. 1, (2019), article 97)
Er is nog veel te doen
Hoeven, J.J.M. van der
2019, Lecture
Effects of short-term fasting on cancer treatment
Groot, S. de; Pijl, H.; Hoeven, J.J. van der ; Kroep, J.R.
2019, Article / Letter to editor (Journal of Experimental & Clinical Cancer Research, vol. 38, iss. 1, (2019), pp. 209)
Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry
Jochems, A.; Kooij, M.K. van der; Fiocco, M.; Schouwenburg, M.G.; Aarts, M.J.; Akkooi, A.C. van; Berkmortel, F. van den; Blank, C.U.; Eertwegh, A.J. van den; Franken, M.G.; Groot, J.B. de; Haanen, J.; Hospers, G.A.; Koornstra, R.H. ; Kruit, W.H.; Louwman, M.; Piersma, D.; Rijn, R.S. van; Suijkerbuijk, K.P.; Tije, A.J. Ten; Vreugdenhil, G.; Wouters, M.; Zeijl, M.C.T. van; Hoeven, K.J.M. van der ; Kapiteijn, E. et al. sine al.
2019, Article / Letter to editor (Cancers, vol. 11, iss. 7, (2019), article E1007)
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy
Bloemendal, M. ; Willigen, W.W. van; Bol, K.F. ; Boers-Sonderen, M.J. ; Bonenkamp, J.J. ; Werner, J.E.M.; Aarntzen, E.H. ; Koornstra, R.H. ; Groot, J.W.B. de; Vries, I.J.M. de ; Hoeven, J.J.M. van der ; Gerritsen, W.R. ; Wilt, J.H.W. de et al. sine al.
2019, Article / Letter to editor (Annals of Surgical Oncology, vol. 26, iss. 12, (2019), pp. 3945-3952)
The occurrence of adverse events in low-risk non-survivors in pediatric intensive care patients: an exploratory study
Verlaat, C.W.M. ; Starre, C. van der; Hazelzet, J.A.; Tibboel, Dick; Hoeven, J.J. van der ; Lemson, J. ; Zegers, M.
2018, Article / Letter to editor (European Journal of Pediatrics, vol. 177, iss. 9, (2018), pp. 1351-1358)
Drug-drug interactions with aprepitant in antiemetic prophylaxis for chemotherapy
Schoffelen, R. ; Lankheet, A.G. ; Herpen, C.M.L. van ; Hoeven, J.J.M. van der ; Desar, I.M.E. ; Kramers, C.
2018, Article / Letter to editor (Netherlands Journal of Medicine, vol. 76, iss. 3, (2018), pp. 109-114)
Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia
Komen, M.M.; Hurk, C.J. van den; Nortier, J.W.; Ploeg, T. van der; Smorenburg, C.H.; Hoeven, J.J.M. van der
2018, Article / Letter to editor (European Journal of Oncology Nursing, vol. 33, (2018), pp. 49-55)
Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands
Franken, M.G.; Leeneman, B.; Jochems, A.; Schouwenburg, M.G.; Aarts, M.J.; Akkooi, Alexander C.J. van; Hoeven, J.J.M. van der ; Koornstra, R.H. ; Haanen, J.B.; Uyl-de Groot, Carin A.
2018, Article / Letter to editor (Anti-Cancer Drugs, vol. 29, iss. 6, (2018), pp. 579-588)
Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands
Jochems, A.; Leeneman, B.; Franken, M.G.; Schouwenburg, M.G.; Aarts, M.J.; Akkooi, Alexander C.J. van; Koornstra, R.H. ; Uyl-de Groot, Carin A.; Hoeven, J.J.M. van der
2018, Article / Letter to editor (Anti-Cancer Drugs, vol. 29, iss. 6, (2018), pp. 572-578)
Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes
Schouwenburg, M.G.; Jochems, A.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J. van den; Haanen, J.; Zeijl, M.C.T. van; Aarts, M.J.; Akkooi, A.C. van; Berkmortel, F. van den; Blokx, W.A.M. ; Groot, J.W.B. de; Hospers, G.A.; Kapiteijn, E.; Koornstra, R.H. ; Kruit, W.H.; Louwman, M.W.; Piersma, D.; Rijn, R.S. van; Suijkerbuijk, K.P.; Tije, A.J. Ten; Vreugdenhil, G.; Wouters, M.; Hoeven, J.J.M. van der et al. sine al.
2018, Article / Letter to editor (Melanoma Research, vol. 28, iss. 4, (2018), pp. 326-332)
[Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry]
Zeijl, M.C.T. van; Eertwegh, A.J. van den; Wouters, M.; Jochems, A.; Schouwenburg, M.G.; Haanen, J.; Aarts, M.J.; Berkmortel, F. van den; Groot, J.W.B. de; Hospers, G.A.; Kapiteijn, E.; Koornstra, R.H. ; Piersma, D.; Rijn, R.S. van; Suijkerbuijk, K.P.; Tije, A.J. Ten; Veldt, A.A.M. van der; Vreugdenhil, G.; Hoeven, K.J.M. van der et al. sine al.
2018, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 162, (2018), article D2420)
Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
Labots, Mariette; Mijn, Johannes C. Van der; Dekker, Henk; Ruijter, Rita; Pham, Thang V.; Vliet, Hans J. Van der; Hoeven, J.J.M. van der ; Meijer, Gerrit A.; Verheul, H.M.W.
2018, Article / Letter to editor (Oncologist, vol. 23, iss. 10, (2018), pp. 1135-+)
Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences
Groot, S. de; Linden, Naomi van der; Franken, M.G.; Blommestein, Hedwig M.; Leeneman, B.; Rooijen, Ellen van; Hoeven, J.J.M. van der ; Westgeest, Hans M.; Uyl-de Groot, Carin A.
2017, Article / Letter to editor (Value in Health, vol. 20, iss. 4, (2017), pp. 627-636)
[70-Gene signature as an aid to treatment decisions in early-stage breast cancer]
Hoeven, J.J.M. van der
2017, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 161, iss. 0, (2017), article D1369)
Oncologie 3.0
Hoeven, J.J.M. van der
2017, Lecture
Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
Groot, S. de; Gelderblom, H.; Fiocco, M.; Bovee, J.V.; Hoeven, J.J.M. van der ; Pijl, H.; Kroep, J.R.
2017, Article / Letter to editor (OncoTargets and Therapy, vol. 10, (2017), pp. 2963-2970)
Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands
Jochems, A.; Schouwenburg, M.G.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J. van den; Haanen, J.B.; Gelderblom, H.; Groot, C.A; Aarts, M.J.; Berkmortel, F.W. van den; Blokx, W.A.M. ; Cardous-Ubbink, M.C.; Groenewegen, G.; Groot, J.W. de; Hospers, G.A.; Kapiteijn, E.; Koornstra, R.H. ; Kruit, W.H.; Louwman, M.W.; Piersma, D.; Rijn, R.S. van; Tije, A.J. Ten; Vreugdenhil, G.; Wouters, M.W.; Hoeven, J.J.M. van der et al. sine al.
2017, Article / Letter to editor (European Journal of Cancer, vol. 72, (2017), pp. 156-165)
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial
Schneider, T.C.; Wit, D. de; Links, T.P.; Erp, N. van ; Hoeven, J.J.M. van der ; Gelderblom, H.; Roozen, I.C.; Bos, M.; Corver, W.E.; Wezel, T. van; Smit, J.W.A. ; Morreau, H.; Guchelaar (LUMC), H.J.; Kapiteijn, E. et al. sine al.
2017, Article / Letter to editor (Journal of Clinical Endocrinology and Metabolism, vol. 102, iss. 2, (2017), pp. 698-707)
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Charehbili, A.; Hamdy, N.A.; Smit, V.T.; Kessels, L; Bochove, A. van; Laarhoven, H.W.M. van ; Putter, H.; Meershoek-Klein Kranenbarg, E.; Leeuwen-Stok, A.E. van; Hoeven, J.J.M. van der ; Velde, C.J. van de; Nortier, J.W.; Kroep, J.R. et al. sine al.
2016, Article / Letter to editor (Breast, vol. 25, (2016), pp. 69-74)
Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia
Komen, M.M.; Breed, W.P.; Smorenburg, C.H.; Ploeg, T. van der; Goey, S.H.; Hoeven, J.J.M. van der ; Nortier, J.W.; Hurk, C.J. van den
2016, Article / Letter to editor (Supportive Care in Cancer, vol. 24, iss. 6, (2016), pp. 2735-2741)
Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer
Hulle, T. van der; Exter, P.L. den; Hoven, P. van den; Hoeven, J.J.M. van der ; Meer, F.J. van der; Eikenboom, J.; Huisman, M.V.; Klok, F.A.
2016, Article / Letter to editor (Chest, vol. 149, iss. 5, (2016), pp. 1245-1251)
Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature
Komen, M.M.; Smorenburg, C.H.; Nortier, J.W.; Ploeg, T. van der; Hurk, C.J. van den; Hoeven, J.J. van der
2016, Article / Letter to editor (Breast, vol. 30, (2016), pp. 105-110)
(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges
Schneider, T.C.; Kapiteijn, E.; Wezel, T. van; Smit, J.W.A. ; Hoeven, J.J.M. van der ; Morreau, H.
2016, Article / Letter to editor (BMC Cancer, vol. 16, (2016), article 31)
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Groot, S. de; Charehbili, A.; Laarhoven, H.W.M. van ; Mooyaart, A.L.; Dekker-Ensink, N.G.; Ven, S. van de; Janssen, L.G.; Swen, J.J.; Smit, V.T.; Heijns, J.B.; Kessels, L.W.; Straaten, T. van der; Bohringer, S.; Gelderblom, H.; Hoeven, J.J. van der ; Guchelaar (LUMC), H.J.; Pijl, H.; Kroep, J.R. et al. sine al.
2016, Article / Letter to editor (Breast Cancer Research, vol. 18, iss. 1, (2016), pp. 3)
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer
Wit, D. de; Schneider, T.C.; Moes, D.J.; Roozen, C.F.; Hartigh, J. den; Gelderblom, H.; Guchelaar (LUMC), H.J.; Hoeven, J.J.M. van der ; Links, T.P.; Kapiteijn, E.; Erp, N. van et al. sine al.
2016, Article / Letter to editor (Cancer Chemotherapy and Pharmacology, vol. 78, iss. 1, (2016), pp. 63-71)
The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study
Groot, S. de; Vreeswijk, M.P.; Welters, M.J.; Gravesteijn, G.; Boei, J.J.; Jochems, A.; Houtsma, D.; Putter, H.; Hoeven, J.J.M. van der ; Nortier, J.W.; Pijl, H.; Kroep, J.R. et al. sine al.
2015, Article / Letter to editor (BMC Cancer, vol. 15, (2015), article 652)
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
Simkens, L.H.; Tinteren, H. van; May, A.; Tije, A.J. Ten; Creemers, G.J.; Loosveld, O.J.; Jongh, F.E. de; Erdkamp, F.L.; Erjavec, Z. ; Torren, A.M. van der; Tol, J. ; Braun, H.J.; Nieboer, P.; Hoeven, J.J.M. van der ; Haasjes, J.G.; Jansen, R.L.; Wals, J.; Cats, A.; Derleyn, V.A.; Honkoop, A.H.; Mol, L. ; Punt, C.J.A. ; Koopman, M. et al. sine al.
2015, Article / Letter to editor (The Lancet (London), vol. 385, iss. 9980, (2015), pp. 1843-1852)
[Ascites drainage at home]
Lutjeboer, J.; Erkel, A.R. van; Hoeven, J.J.M. van der ; Meer, R.W. van der
2015, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 159, (2015), pp. A9326)
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
Dijkgraaf, E.M.; Santegoets, S.J.; Reyners, A.K.; Goedemans, R.; Nijman, H.W.; Poelgeest, M.I.E. van; Erkel, A.R. van; Smit, V.T.; Daemen, T.A.; Hoeven, J.J.M. van der ; Melief, C.J.; Welters, M.J.; Kroep, J.R.; Burg, S.H. van der et al. sine al.
2015, Article / Letter to editor (Oncotarget, vol. 6, iss. 31, (2015), pp. 32228-32243)
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha2b in patients with recurrent epithelial ovarian cancer
Dijkgraaf, E.M.; Santegoets, S.J.; Reyners, A.K.; Goedemans, R.; Wouters, M.C.; Kenter, G.G.; Erkel, A.R. van; Poelgeest, M.I.E. van; Nijman, H.W.; Hoeven, J.J.M. van der ; Welters, M.J.; Burg, S.H. van der; Kroep, J.R. et al. sine al.
2015, Article / Letter to editor (Annals of Oncology, vol. 26, iss. 10, (2015), pp. 2141-2149)
Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: current and future evidence
Blok, E.J.; Derks, M.G.; Hoeven, J.J.M. van der ; Velde, C.J. van de; Kroep, J.R.
2015, Article / Letter to editor (Cancer Treatment Reviews, vol. 41, iss. 3, (2015), pp. 271-276)
Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach
Morgans, A.K.; Bommel, A.C. van; Stowell, C.; Abrahm, J.L.; Basch, E.; Bekelman, J.E.; Berry, D.L.; Bossi, A.; Davis, I.D.; Reijke, T.M. de; Denis, L.J.; Evans, S.M.; Fleshner, N.E.; George, D.J.; Kiefert, J.; Lin, D.W.; Matthew, A.G.; McDermott, R.; Payne, H.; Roos, I.A.; Schrag, D.; Steuber, T.; Tombal, B.; Basten, J.P. van; Hoeven, J.J.M. van der ; Penson, D.F. et al. sine al.
2015, Article / Letter to editor (European Urology, vol. 68, iss. 5, (2015), pp. 891-898)
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial
Schneider, T.C.; Wit, D. de; Links, T.P.; Erp, N. van ; Hoeven, J.J.M. van der ; Gelderblom, H.; Wezel, T. van; Eijk, R. van; Morreau, H.; Guchelaar (LUMC), H.J.; Kapiteijn, E. et al. sine al.
2015, Article / Letter to editor (International Journal of Endocrinology, vol. 2015, (2015), pp. 348124)
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation.
Tol, J. ; Cats, A.; Mol, L. ; Koopman, M. ; Bos, M.M. ; Hoeven, J.J.M. van der ; Antonini, N.; Krieken, J.H.J.M. van ; Punt, C.J.A.
2008, Article / Letter to editor (Investigational New Drugs, vol. 26, iss. 4, (2008), pp. 393-397)
Spontaneous fracture of implanted central venous catheters s in cancer patients: report of two cases and retrospective analysis of the 'pinch-off-sign' as a risk factor
Punt, C.J.A. ; Strijk, S.P. ; Hoeven, J.J.M. van der ; Sluis, R.F. van der ; Verhagen, C.A.H.H.V.M.
1995, Article / Letter to editor (Anti-Cancer Drugs, vol. 6, (1995), pp. 594-598)
Spontaneus fracture of implanted central venous catheter in cancer patients: report of 2 cases and retrospective analysis of the pinch-off-sign as a risk factor.
Punt, C.J.A. ; Strijk, S.P. ; Hoeven, J.J.M. van der ; Sluis, R.F. van der ; Verhagen, C.A.H.H.V.M.
1995, Article / Letter to editor (Anti-Cancer Drugs, vol. 6, (1995), pp. 594-598)

Now showing items 1-44 of 44

Search Repository

Browse

All of Repository

Radboud Repository

Browsing by Author "Hoeven, J.J.M. van der"

Search Repository

Browse

All of Repository